A Study to Assess the Feasibility of Non-invasive Dried Blood Sampling

Clinical trial NCT05492734 · COMPLETED

Trial details

NCT number: NCT05492734
Sponsor: Edgewise Therapeutics, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Muscular Dystrophies

Start date: 2022-08-12
Primary completion: 2022-08-19
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.